Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2
Autor: | Dongqi Tang, Yimu Lai, Joseph S. Janicki, Xing Li Wang, Sao Cong Sun, Bin Li, Siying Li, Haibo Song, Wenjuan Wang, Taixing Cui, Hui Wang, Chen Qu, Bryan J. Mathis, Lei Shao |
---|---|
Rok vydání: | 2015 |
Předmět: |
Male
MAPK/ERK pathway medicine.medical_specialty NF-E2-Related Factor 2 Down-Regulation Cardiomegaly Biology medicine.disease_cause Models Biological p38 Mitogen-Activated Protein Kinases Deubiquitinating enzyme Deubiquitinating Enzyme CYLD Proto-Oncogene Proteins c-myc Downregulation and upregulation Ubiquitin Internal medicine Pressure medicine Animals Humans Myocytes Cardiac Gene Silencing Extracellular Signal-Regulated MAP Kinases Molecular Biology Ultrasonography Heart Failure Mice Knockout Pressure overload Ventricular Remodeling Myocardium Tumor Suppressor Proteins Survival Analysis Rats Up-Regulation Cell biology Transcription Factor AP-1 Cysteine Endopeptidases Oxidative Stress Endocrinology Proteasome Gene Knockdown Techniques biology.protein Cardiology and Cardiovascular Medicine Ubiquitin Thiolesterase Oxidative stress Signal Transduction |
Zdroj: | Journal of Molecular and Cellular Cardiology. 84:143-153 |
ISSN: | 0022-2828 |
DOI: | 10.1016/j.yjmcc.2015.04.012 |
Popis: | Ubiquitin proteasome system (UPS) consists of ubiquitin, ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), ubiquitin ligases (E3s), proteasomes, and deubiquitinating enzymes (DUBs). Ubiquitin, E1s, several E2s, E3s, and proteasomes play an important role in the regulation of cardiac homeostasis and dysfunction; however, less is known about the role of DUBs in the heart. Here, we uncovered a crucial role of cyclindromatosis (CYLD), a DUB, in mediating cardiac maladaptive remodeling and dysfunction. CYLD expression was dramatically upregulated in the cardiomyocytes of hypertrophic and failing human and murine hearts. Knockout of CYLD improved survival rate and alleviated cardiac hypertrophy, fibrosis, apoptosis, oxidative stress, and dysfunction in mice that were subjected to sustained pressure overload induced by transverse aortic constriction. Deep sequencing and gene array analyses revealed that the most dramatically changed genes are those involving in the free radical scavenging pathway and cardiovascular disease, including fos, jun, myc, and nuclear factor erythroid-2 related factor 2 (Nrf2) in the heart. Moreover, knockdown of CYLD enhanced mitogen-activated protein kinase (MAPK) ERK- and p38-mediated expression of c-jun, c-fos, and c-myc, which govern Nrf2 expression in cardiomyocytes. The CYLD deficiency-induced suppression of reactive oxygen species (ROS) formation, death and hypertrophy in cardiomyocytes was blocked by additional knockdown of Nrf2. Taken together, our findings demonstrate for the first time that CYLD mediates cardiac maladaptive remodeling and dysfunction, most likely via enhancing myocardial oxidative stress in response to pressure overload. At the molecular level, CYLD interrupts the ERK- and p38-/AP-1 and c-Myc pathways to suppress Nrf2-operated antioxidative capacity, thereby enhancing oxidative stress in the heart. |
Databáze: | OpenAIRE |
Externí odkaz: |